Notice of Pre-Application Webinar for RFA-AG-19-010: "Alzheimer Centers for Discovery of New Medicines (U54 Clinical Trial Not Allowed)"

Notice Number: NOT-AG-18-028

Key Dates
Release Date: September 21, 2018

Related Announcements
RFA-AG-19-010

Issued by
National Institute on Aging (NIA)

Purpose

The purpose of this Notice is to inform potential applicants that the NIA will hold pre-application, technical assistance webinars regarding applications for RFA-AG-19-010 on Thursday, October 11 and Tuesday, October 16 from 1:00 - 2:30 PM EST.

RFA-AG-19-010 invites U54 Cooperative Agreement applications aiming to establish multi-component Alzheimer Centers for the Discovery of New Medicines. The overarching purpose of this Centers program is to improve, diversify and reinvigorate the Alzheimer's disease (AD) drug development pipeline by accelerating the characterization and experimental validation of next generation therapeutic targets and integrating the targets into drug discovery campaigns. To this end, the funded Centers will 1) design, develop and disseminate tools that support target enabling packages (TEPs) for the experimental validation of novel, next generation therapeutic targets, including those emanating from the NIA-funded, target discovery programs such as AMP-AD, and 2) initiate early stage drug discovery campaigns against the enabled targets.

The purpose and objectives of the RFA will be reviewed during the webinars. Written questions submitted by participants either prior to or during the webinar will also be addressed. Potential applicants are strongly encouraged to submit questions prior to the webinars to [email protected]. Please indicate "U54 Clinical Centers Webinar" in the subject line of the email.

Potential applicants interested in participating in the webinar should register by sending an email to [email protected] at least one week prior to the event date. Please indicate "U54 Webinar Registration" in the subject line of the email. Call-in information will be provided once registration is received.

The webinar is optional and is not required for submission to the FOA.

Inquiries

Please direct all inquiries to:

Lorenzo M. Refolo, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-594-7576
Email: [email protected]